Nuzenio

Fhtx

Fhtx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Wall Street Zen Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to Hold - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:04 GMT Discipline and Rules-Based Execution in FHTX Response - Stock Traders DailyStock Traders Daily · Fri, 07 Aug 2026 03:36:02 GMT Foghorn Therapeutics (NASDAQ:FHTX) Issues Earnings Results, Beats Estimates By $0.13 EPS - MarketBeatMarketBeat · Fri, 07 Aug 2026 03:34:50 GMT FHTX: Precision oncology pipeline and Lilly partnership drive growth in chromatin-targeted therapeutics - TradingViewTradingView · Thu, 06 Aug 2026 14:39:44 GMT Foghorn Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 14:20:38 GMT Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:06 GMT FHTX: Reduced net loss, robust pipeline progress, and strong cash position support growth into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:13:51 GMT Foghorn Therapeutics Inc. 2026: Revenue $16.07M, EPS ($0.1) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMT

Timeline

Sat, 08 Aug 2026 06:05:04 GMTWall Street Zen Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to Hold - MarketBeat

Fri, 07 Aug 2026 03:36:02 GMTDiscipline and Rules-Based Execution in FHTX Response - Stock Traders Daily

Fri, 07 Aug 2026 03:34:50 GMTFoghorn Therapeutics (NASDAQ:FHTX) Issues Earnings Results, Beats Estimates By $0.13 EPS - MarketBeat

Thu, 06 Aug 2026 14:39:44 GMTFHTX: Precision oncology pipeline and Lilly partnership drive growth in chromatin-targeted therapeutics - TradingView

Thu, 06 Aug 2026 14:20:38 GMTFoghorn Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView

Thu, 06 Aug 2026 13:50:06 GMTFoghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Foghorn Therapeutics Inc10 live mentions NASDAQ8 live mentions Inc5 live mentions Revenue Breakdown4 live mentions EPS3 live mentions TradingView FHTX3 live mentions TradingView TradingView3 live mentions TradingView Foghorn Therapeutics3 live mentions Price3 live mentions Discipline2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fhtx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.